Arkolith/Insider Trading/LAB/Form 4

Kim Hanjoon Alex

Chief Financial OfficerSTANDARD BIOTOOLS INC. (LAB) · full profile →Form 4 · filed Apr 8, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
5
3 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 6, 2026Option exercise(M)70K—$02.8M
Apr 6, 2026Tax withholding(F)21K$0.91$19K2.8M
Mar 20, 2026Grant(A)323K—$02.7M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 6, 2026Option exercise(M)70K—$00
Mar 20, 2026Grant(A)727K—$0727K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-148613) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML